Andrew Craig Miller - Nov 10, 2022 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Operating Officer
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Nov 10, 2022
Transactions value $
-$3,379,510
Form type
4
Date filed
11/14/2022, 03:21 PM
Previous filing
Nov 3, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $7.27K +1K +2.6% $7.27* 39.5K Nov 11, 2022 Direct
transaction KRTX Common Stock Options Exercise $2.92K +1K +2.53% $2.92* 40.5K Nov 11, 2022 Direct
transaction KRTX Common Stock Sale -$3.39M -15K -37.04% $225.98 25.5K Nov 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -1K -7.8% $0.00 11.8K Nov 11, 2022 Common Stock 1K $7.27 Direct F2
transaction KRTX Option (right to buy) Options Exercise $0 -1K -1.77% $0.00 55.4K Nov 11, 2022 Common Stock 1K $2.92 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2022.
F2 This option vested as to 1/30th of the shares underlying the option award on each one month anniversary of the vesting commencement date of August 15, 2018.
F3 This option vested as to 1/16th of the shares underlying the option award on the vesting commencement date of July 18, 2016 and as to an additional 1/16th of the shares on each three month anniversary thereafter.